| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $21.1M | — | -48.2% |
| Cost of Revenue | $9.8M | — | -53.3% |
| Gross Profit | $11.3M | — | -42.7% |
| R&D Expense | $2.1M | — | -81.3% |
| SG&A Expense | $18.6M | — | -51.9% |
| Operating Income | -$12.5M | — | +62.1% |
| Pre-tax Income | -$14.6M | — | +44.2% |
| Income Tax | $11K | — | +107.3% |
| Net Income | $127.1M | — | +588.1% |
| EPS (Basic) | $0.33 | — | +571.4% |
| EPS (Diluted) | $0.33 | — | +571.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $265.8M | +119.9% | +76.1% |
| Accounts Receivable | $16.6M | +23.9% | -53.1% |
| Inventory | $18.6M | -6.9% | -55.9% |
| Current Assets | $521.5M | +14.8% | +51.6% |
| Total Assets | $639.1M | +12.6% | +10.3% |
| Current Liabilities | $42.2M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$46.6M | — | -53.9% |
| Capital Expenditures | $570K | — | -88.7% |
| Investing Cash Flow | $191.1M | — | +1206.6% |
| Financing Cash Flow | -$40K | — | +13.0% |
| Free Cash Flow | -$47.2M | — | -33.5% |
| -25.0% |
| Total Liabilities | $78.0M | -45.6% | -37.6% |
| Stockholders' Equity | $561.1M | +32.2% | +23.4% |